Description
Agilent Technologies: What the Next Instrument Cycle Looks Like—Inside the LC & LC/MS Modernization Tailwind!
Agilent Technologies, Inc. recently reported its fourth-quarter results for fiscal year 2025, showcasing robust performance across numerous dimensions. The company’s revenue for the quarter was $1.86 billion, representing growth of 7.2% on a core basis. This marked Agilent’s sixth consecutive quarter of core revenue growth acceleration, with the results surpassing the high end of their guidance range. The company attributed this strong performance to broad-based momentum across its product portfolio, notably in the LC and LC/MS sectors, and impressive contributions from the CDMO segment and key regions. Agilent’s innovative product launches played a pivotal role in driving growth, with the company’s customer-centric innovations, like the Infinity III LC and the Pro iQ LC/MS systems, showing significant traction. The Pro iQ, in particular, enjoyed a noteworthy ramp in sales within the pharma and biotech markets.
